NEW YORK (Reuters Health) – Intravenous magnesium sulfate (MgSO4) does not benefit patients with acute aneurysmal subarachnoid hemorrhage, according to results of a phase III trial. In the…
NEW YORK (Reuters Health) – Children with severe combined immunodeficiency (SCID) do better when they receive stem cell transplantation during infancy, according to a systematic review published online…
NEW YORK (Reuters Health) – The “dramatic benefits” of probiotic supplements for reducing death and necrotizing enterocolitis (NEC) in very low birth weight (VLBW) preterm neonates have been…
NEW YORK (Reuters Health) – Positron emission tomography (PET) of the liver is extremely unreliable in patients who’ve just had chemotherapy for colorectal cancer metastases, because the false-negative…
NEW YORK (Reuters Health) – Intra-arterial fibrinolysis improves outcomes after acute ischemic stroke, a meta-analysis confirms — and although the treatment increases the risk of hemorrhage, that doesn’t…
NEW YORK (Reuters Health) – Urinary dipstick and microscopy testing are not good at finding urinary tract infection when pain is not one of the symptoms, UK researchers…
NEW YORK (Reuters Health) – Patients on long-term stable warfarin therapy can safely be immunized against influenza, results of study from Italy indicate. In the study, influenza vaccination…
NEW YORK (Reuters Health) – Polymerase chain reaction (PCR) analysis of dried blood spots is an insensitive means of neonatal screening for cytomegalovirus (CMV) infection, a large study…
NEW YORK (Reuters Health) – In adults with moderate-to-severe active Crohn’s disease, treatment with infliximab plus azathioprine, or infliximab alone, led to significantly higher rates of corticosteroid-free clinical…
NEW YORK (Reuters Health) – Octogenarians with heart failure have a higher risk of in-hospital death after defibrillator or pacemaker placement, compared to younger patients, new research shows.…
